Is Tenaya Therapeutics Inc (NASDAQ:TNYA) Expensive At $0.53? Here’s How To Know.

In last trading session, Tenaya Therapeutics Inc (NASDAQ:TNYA) saw 2.77 million shares changing hands with its beta currently measuring 2.92. Company’s recent per share price level of $0.53 trading at $0.04 or 7.49% at ring of the bell on the day assigns it a market valuation of $85.68M. That closing price of TNYA’s stock is at a discount of -666.04% from its 52-week high price of $4.06 and is indicating a premium of 32.08% from its 52-week low price of $0.36. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.84 million shares which gives us an average trading volume of 3.51 million if we extend that period to 3-months.

For Tenaya Therapeutics Inc (TNYA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.18 in the current quarter.

Tenaya Therapeutics Inc (NASDAQ:TNYA) trade information

Tenaya Therapeutics Inc’s shares saw a change of -63.17% in year-to-date performance and have moved 19.24% in past 5-day. Tenaya Therapeutics Inc (NASDAQ:TNYA) showed a performance of 5.83% in past 30-days. Number of shares sold short was 12.16 million shares which calculate 5.72 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -15.48% during past 5 years.

Tenaya Therapeutics Inc (NASDAQ:TNYA)’s Major holders

Insiders are in possession of 0.72% of company’s total shares while institution are holding 59.73 percent of that, with stock having share float percentage of 60.16%. Investors also watch the number of corporate investors in a company very closely, which is 59.73% institutions for Tenaya Therapeutics Inc that are currently holding shares of the company. COLUMN GROUP LLC is the top institutional holder at TNYA for having 9.4 million shares of worth $29.14 million. And as of 2024-06-30, it was holding 10.968 of the company’s outstanding shares.

The second largest institutional holder is RA CAPITAL MANAGEMENT, L.P., which was holding about 7.62 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.8935 of outstanding shares, having a total worth of $23.63 million.

On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 2.88 shares of worth $1.52 million or 1.77% of the total outstanding shares. The later fund manager was in possession of 1.47 shares on Mar 31, 2025 , making its stake of worth around $0.77 million in the company or a holder of 0.90% of company’s stock.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.